Takacs Peter, De Santis Timothy, Nicholas M Catherine, Verma Usha, Strassberg Richard, Duthely Lunthita
Department of Obstetrics and Gynecology, D-50, Jackson Memorial Hospital, University of Miami School of Medicine, PO Box 016960, Miami, FL 33010 USA.
J Ultrasound Med. 2005 Nov;24(11):1477-81. doi: 10.7863/jum.2005.24.11.1477.
The purpose of this study was to assess postmenopausal women with endometrial fluid collection and the risk of significant endometrial or cervical disease.
A retrospective chart review was conducted of 343 postmenopausal women with endometrial fluid collection on pelvic sonography. Medical records were reviewed to identify women who underwent an evaluation of the endometrium with endometrial biopsy, hysteroscopy, or hysterectomy after the sonographic examination. Clinical and sonographic characteristics were compared between women with diagnoses of cervical or endometrial cancer or hyperplasia (nonbenign group) and women with benign conditions (benign group).
The endometrium was significantly thicker in the nonbenign group compared with the benign group (mean +/- SD, 9.9 +/- 7.4 versus 5.9 +/- 4.1 mm; P = .016). None of the patients with adenocarcinoma of the endometrium had endometrial thickness of 3 mm or less, but 2 with endocervical cancer did. Echogenic fluid in the endometrial cavity was significantly more likely to be found in the nonbenign group compared with the benign group (45.8% versus 4.8%; P < .01). Multivariate logistic regression analysis revealed that echogenic fluid in the endometrial cavity was the only significant risk factor for nonbenign conditions (odds ratio, 10.94; 95% confidence interval, 2.67-44.84; P < .01).
Postmenopausal women with endometrial fluid collection on sonography should undergo endometrial sampling if the endometrial lining is thicker than 3 mm or the endometrial fluid is echogenic. If the lining is 3 mm or less and the endometrial fluid is clear, endometrial sampling is not necessary, but we recommend endocervical sampling to rule out endocervical cancer.
本研究旨在评估有子宫内膜积液的绝经后女性以及发生严重子宫内膜或宫颈疾病的风险。
对343例经盆腔超声检查发现有子宫内膜积液的绝经后女性进行回顾性病历分析。查阅病历以确定在超声检查后接受子宫内膜活检、宫腔镜检查或子宫切除术进行子宫内膜评估的女性。比较诊断为宫颈癌或子宫内膜癌或增生的女性(非良性组)和患有良性疾病的女性(良性组)的临床和超声特征。
与良性组相比,非良性组的子宫内膜明显更厚(平均±标准差,9.9±7.4对5.9±4.1毫米;P = 0.016)。子宫内膜癌患者中无一例子宫内膜厚度小于或等于3毫米,但有2例宫颈癌患者的子宫内膜厚度小于或等于3毫米。与良性组相比,非良性组子宫内膜腔内出现强回声液的可能性明显更高(45.8%对4.8%;P < 0.01)。多因素逻辑回归分析显示,子宫内膜腔内的强回声液是发生非良性疾病的唯一显著危险因素(比值比,10.94;95%置信区间,2.67 - 44.84;P < 0.01)。
超声检查发现有子宫内膜积液的绝经后女性,如果子宫内膜厚度大于3毫米或子宫内膜液为强回声,则应进行子宫内膜取样。如果内膜厚度为3毫米或更小且子宫内膜液清晰,则无需进行子宫内膜取样,但我们建议进行宫颈取样以排除宫颈癌。